Literature DB >> 11292726

Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin.

R Latif1, N Kerlero de Rosbo, T Amarant, R Rappuoli, G Sappler, A Ben-Nun.   

Abstract

Pertussis toxin (PT), a holomer consisting of a catalytic S1 subunit and a B oligomer composed of S2-S4 and S3-S4 dimers, held together by the S5 subunit, exerts profound effects on immune cells, including T-cell mitogenicity. While the mitogenic activity of PT was shown to reside fully within the B oligomer, it could not be assigned to any particular B-oligomer component. In this study, we purified the S3-S4 dimer to homogeneity under conditions propitious to maintenance of the native conformation. In contrast to previous reports which suggested that both S3-S4 and S2-S4 dimers are necessary for mitogenic activity, our preparation of the highly purified S3-S4 dimer was as strongly mitogenic as the B oligomer, suggesting that the S3-S4 dimer accounts for the mitogenic activity of the B oligomer. Moreover, in vitro stimulation of naive lymphocytes by the S3-S4 dimer resulted in reversal of the normal CD4(+)/CD8(+) T-cell ratio from approximately 2:1 to 1:2. The reversal of the CD4(+)/CD8(+) T-cell ratio is unlikely to be due to preferential apoptosis-necrosis of CD4(+) T cells, as indicated by fluorescence-activated cell sorter analysis of annexin-stained T-cell subsets, or to preferential stimulation of CD8(+) T cells. The mechanism underlying the reversal requires further investigation. Nevertheless, the data presented indicate that the S3-S4 dimer may have potential use in the context of diseases amenable to immunological modulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292726      PMCID: PMC98262          DOI: 10.1128/IAI.69.5.3073-3081.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages.

Authors:  J van't Wout; W N Burnette; V L Mar; E Rozdzinski; S D Wright; E I Tuomanen
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

2.  Mutants of pertussis toxin suitable for vaccine development.

Authors:  M Pizza; A Covacci; A Bartoloni; M Perugini; L Nencioni; M T De Magistris; L Villa; D Nucci; R Manetti; M Bugnoli
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

3.  Pertussis toxin has eukaryotic-like carbohydrate recognition domains.

Authors:  K Saukkonen; W N Burnette; V L Mar; H R Masure; E I Tuomanen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

4.  Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.

Authors:  A Kimura; K T Mountzouros; P A Schad; W Cieplak; J L Cowell
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  Binding of pertussis toxin to eucaryotic cells and glycoproteins.

Authors:  M H Witvliet; D L Burns; M J Brennan; J T Poolman; C R Manclark
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

6.  Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit.

Authors:  T D Bartley; D W Whiteley; V L Mar; D L Burns; W N Burnette
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Interaction of pertussis toxin with human T lymphocytes.

Authors:  M H Witvliet; M L Vogel; E J Wiertz; J T Poolman
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

8.  ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis.

Authors:  W J Black; J J Munoz; M G Peacock; P A Schad; J L Cowell; J J Burchall; M Lim; A Kent; L Steinman; S Falkow
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

9.  Structure-function relationship of islet-activating protein, pertussis toxin: biological activities of hybrid toxins reconstituted from native and methylated subunits.

Authors:  K Nogimori; M Tamura; M Yajima; N Hashimura; S Ishii; M Ui
Journal:  Biochemistry       Date:  1986-03-25       Impact factor: 3.162

Review 10.  ADP-ribosylation of signal-transducing guanine nucleotide-binding proteins by pertussis toxin.

Authors:  P Gierschik
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

View more
  6 in total

1.  Acellular pertussis vaccines and complement killing of Bordetella pertussis.

Authors:  Alison A Weiss; Angela K Patton; Scott H Millen; Swei-Ju Chang; Joel I Ward; David I Bernstein
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  A hybrid multi-compartment model of granuloma formation and T cell priming in tuberculosis.

Authors:  Simeone Marino; Mohammed El-Kebir; Denise Kirschner
Journal:  J Theor Biol       Date:  2011-04-01       Impact factor: 2.691

3.  Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells.

Authors:  Scott H Millen; David I Bernstein; Beverly Connelly; Joel I Ward; Swei-Ju Chang; Alison A Weiss
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4.

Authors:  Olivia D Schneider; Alison A Weiss; William E Miller
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

5.  Predicting lymph node output efficiency using systems biology.

Authors:  Chang Gong; Joshua T Mattila; Mark Miller; JoAnne L Flynn; Jennifer J Linderman; D Kirschner
Journal:  J Theor Biol       Date:  2013-06-29       Impact factor: 2.691

Review 6.  Integrative lymph node-mimicking models created with biomaterials and computational tools to study the immune system.

Authors:  Yufeng Shou; Sarah C Johnson; Ying Jie Quek; Xianlei Li; Andy Tay
Journal:  Mater Today Bio       Date:  2022-04-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.